Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shuji Suzuki is active.

Publication


Featured researches published by Shuji Suzuki.


Chemotherapy | 1992

Changes in Serum Erythropoietin Levels during Chemotherapy for Lung Cancer

Yasuo Saijo; Yushi Nakai; Junichi Saito; Shunichi Sugawara; Shuji Suzuki; Yuka Numata; Masakichi Motomiya

Serial serum erythropoietin (EPO) levels were measured in 12 adult lung cancer patients during cancer chemotherapy. In major cases, EPO levels increased significantly after chemotherapy while the hemoglobin (Hb) remained at initial levels. EPO fell gradually or rapidly to initial levels after a peak, although the patients were anemic. The increase of EPO levels was linearly related to the decrease in Hb (y = 17.48x + 1.003). The mechanism of the rapid increase of EPO is not simply explained by anemia, but might be related to new synthesis, corresponding to depressed bone marrow.


Tohoku Journal of Experimental Medicine | 1985

Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung carcinoma (3LL) in C57Bl/6 (B6) mice.

Nobuko Kumano; Tetsuko Ishikawa; Sadahiro Koinumaru; Tomoyoshi Kikumoto; Shuji Suzuki; Yushi Nakai; Kiyoshi Konno


Tohoku Journal of Experimental Medicine | 1998

Exogenous Recombinant Human IL-12 Augments MHC Class I Antigen Expression on Human Cancer Cells in vitro.

Shuji Suzuki; Yasuiki Umezu; Yasuo Saijo; George Satoh; Y. Abe; Ken Satoh; Toshihiro Nukiwa


Tohoku Journal of Experimental Medicine | 1985

Imbalance of T cell subsets in cancer patients and its modification with bestatin, a small molecular immunomodifier.

Nobuko Kumano; Shuji Suzuki; Kotaro Oizumi; Kiyoshi Konno; Tatsumi Himori; Yasushi Mitachi; Akira Wakui


Tohoku Journal of Experimental Medicine | 1985

Changes in the Immunological Parameters after a Single Dose of Forphenicinol, a New Small Molecular Immunomodifier

Nobuko Kumano; Yushi Nakai; Tetsuko Ishikawa; Sadahiro Koinumaru; Shuji Suzuki; Kotaro Oizumi; Kiyoshi Konno


Tohoku Journal of Experimental Medicine | 1992

Protein Kinase C Activity in Human Leukemia Cell Lines with Reference to Sensitivity to Antineoplastic Agents

Shunichi Sugawara; Nobuko Kumano; Yasuo Saijo; Shuji Suzuki; Yuka Numata; George Sato; Masakichi Motomiya


Tohoku Journal of Experimental Medicine | 1989

Establishment of an etoposide (VP-16)-resistant subline of THP-1 human monocytic leukemia cell line.

Yasuo Saijo; Nobuko Kumano; Shuji Suzuki; Sadahiro Koinumaru; Shunichi Sugawara; Kotaro Oizumi; Masakichi Motomiya


Tohoku Journal of Experimental Medicine | 1985

Antitumor effect of the yeast polysaccharide preparation in syngeneic mouse tumor models.

Nobuko Kumano; Shuji Suzuki; Tetsuko Ishikawa; Sadahiro Koinumaru; Kiyoshi Konno


Tohoku Journal of Experimental Medicine | 1981

Prophylaxis of 3-methylcholanthrene-induced tumorigenesis in mice with the yeast polysaccharide preparation.

Nobuko Kumano; Tomoyoshi Kikumoto; Sadahiro Koinumaru; Yushi Nakai; Tetsuko Ishikawa; Shuji Suzuki; Kiyoshi Konno


Tohoku Journal of Experimental Medicine | 1992

Chemotherapy in Small Cell Lung Cancer -From View Point of Dose Intensity-

Yushi Nakai; Sadahiro Koinumaru; Shuji Suzuki; Junichi Saito; Shunichi Sugawara; Yuka Numata; Joji Sato; Nobuyuki Matsubara; Masakichi Motomiya

Collaboration


Dive into the Shuji Suzuki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge